Literature DB >> 21327905

[Benign esophageal disorders. Gastroesophageal reflux disease, diffuse esophageal spasm, achalasia].

K-H Fuchs1, W Breithaupt.   

Abstract

Gastroesophageal reflux disease (GERD) is the most frequent benign disorder of the upper gastrointestinal (GI) tract and other defined disease entities, such as achalasia and diffuse esophageal spasm, also belong to this group. In addition to surgical therapy, medicinal therapy also has an important role in all 3 of these disorders. Therefore, it is very important to follow precise indication criteria based on diagnostic evaluation and patient selection as well as to use an optimal operative technique.The therapeutic spectrum for achalasia varies from Botox injections and endoscopic dilatation to laparoscopic myotomy which achieves a success rate up to 90%.Patients with diffuse spasm suffer from severe dysphagia, thoracic pain and burning sensations and even respiratory problems. Surgical therapy consists of thoracoscopic long myotomy and in selective cases with persisting pain even esophagectomy and gastric pull-up.Therapeutic options for GERD predominantly involve conservative medicinal therapy with proton pump inhibitors and selective laparoscopic antireflux procedures. Minimally invasive techniques have led to a higher acceptance of surgical therapy. The two major procedures most frequently used are total Nissen fundoplication and posterior partial Toupet fundoplication.

Entities:  

Mesh:

Year:  2011        PMID: 21327905     DOI: 10.1007/s00104-010-2033-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

1.  Randomized trial to study the effect of fundic mobilization on long-term results of Nissen fundoplication.

Authors:  M E Luostarinen; J O Isolauri
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

2.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

Review 3.  Minimally invasive surgery for esophageal motility disorders.

Authors:  Nagammapudur S Balaji; Jeffrey H Peters
Journal:  Surg Clin North Am       Date:  2002-08       Impact factor: 2.741

4.  Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

Authors:  E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

5.  [Conventional and minimally invasive surgical methods for gastroesophageal reflux].

Authors:  K-H Fuchs
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

6.  A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia.

Authors:  Constantine T Frantzides; Atul K Madan; Mark A Carlson; George P Stavropoulos
Journal:  Arch Surg       Date:  2002-06

7.  Laparoscopic mesh-augmented hiatoplasty as a treatment of gastroesophageal reflux disease and hiatal hernias-preliminary clinical and functional results of a prospective case series.

Authors:  Beat P Müller-Stich; Georg R Linke; Jan Borovicka; Francesco Marra; René Warschkow; Jochen Lange; Arianeb Mehrabi; Jörg Köninger; Carsten N Gutt; Andreas Zerz
Journal:  Am J Surg       Date:  2008-03-26       Impact factor: 2.565

Review 8.  Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis.

Authors:  Guilherme M Campos; Eric Vittinghoff; Charlotte Rabl; Mark Takata; Michael Gadenstätter; Feng Lin; Ruxandra Ciovica
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

Review 9.  Mesh complications after prosthetic reinforcement of hiatal closure: a 28-case series.

Authors:  Rudolf J Stadlhuber; Amr El Sherif; Sumeet K Mittal; Robert J Fitzgibbons; L Michael Brunt; John G Hunter; Tom R Demeester; Lee L Swanstrom; C Daniel Smith; Charles J Filipi
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

10.  Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Authors:  L Lundell; S Attwood; C Ell; R Fiocca; J-P Galmiche; J Hatlebakk; T Lind; O Junghard
Journal:  Gut       Date:  2008-05-09       Impact factor: 23.059

View more
  1 in total

1.  Evaluation of short-term and long-term results after laparoscopic antireflux surgery: esophageal manometry and 24-h pH monitoring versus quality of life index.

Authors:  Katarzyna Blazejczyk; Andreas Hoene; Anne Glitsch; Alexandra Busemann; Claus Dieter Heidecke; Maciej Patrzyk
Journal:  Langenbecks Arch Surg       Date:  2013-09-15       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.